InvestorsHub Logo
Followers 4
Posts 1483
Boards Moderated 0
Alias Born 12/11/2013

Re: None

Tuesday, 09/05/2017 8:23:42 AM

Tuesday, September 05, 2017 8:23:42 AM

Post# of 38634
Reading through the new CFO PR; he seems to be the perfect fit.

I believe some words were spcifically put in there by IPCI:

" has deep expertise in all facets of business, including operations,
trade,
finance,
regulatory and business development,
both nationally and internationally.

helped grow .....to a 12-drug, 36 country international platform.

oversaw several significant acquisitions,

and implemented a low-cost operating model

investor relations,

and negotiating and executing key agreements for distribution and sales of products

Mr. Patient added, “Intellipharmaceutics has an expansive pipeline of high potential products and technology platforms - I look forward to working with Dr. Odidi and the Intellipharmaceutics team to help bring the Company to the next level in its development.”

@ Impact: 6 dollar per share buyout would mean a 180Mln company value. IF Regabatin gets partnered (via standard practice agreements with a big pharma) and IF Prodras proves itslef valid in human trials I see the company value North of 500Mln. likely in mid 2018, not NOW. 6 dollar could only be part of a much complex Agreement made of several milestones. I don't see it happening any time soon.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent IPCI News